sr141716 has been researched along with Aura in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calignano, A; Citraro, R; De Sarro, G; Ngomba, RT; Nicoletti, F; Russo, E; Scicchitano, F; Whalley, BJ | 1 |
| Bogdanovic, RM; Jafari, M; Potschka, H; von Rüden, EL; Wotjak, CT | 1 |
| Lutz, B; Monory, K | 1 |
| Bevan, SA; Hill, AJ; Jones, NA; Smith, I; Stephens, GJ; Weston, SE; Whalley, BJ; Williams, CM; Williamson, EM | 1 |
| Pitkänen, A | 1 |
| Karr, L; Pan, YZ; Rutecki, PA | 1 |
| Dudek, FE; Pouliot, WA; Rossi, CA; Staley, KJ | 1 |
| Azad, SC; Behl, C; Cannich, A; Casanova, E; Cascio, MG; Di Marzo, V; Eder, M; Goodenough, S; Gutiérrez, SO; Hermann, H; López-Rodriguez, ML; Lutz, B; Marsicano, G; Monory, K; Schütz, G; van der Stelt, M; Zieglgänsberger, W | 1 |
| Blair, RE; Carter, DS; DeLorenzo, RJ; Deshpande, LS; Martin, BR; Sombati, S | 1 |
| Ameri, A; Simmet, T; Wilhelm, A | 1 |
1 review(s) available for sr141716 and Aura
| Article | Year |
|---|---|
Therapeutic approaches to epileptogenesis--hope on the horizon.
Topics: Animals; Anticonvulsants; Epilepsy; Epilepsy, Post-Traumatic; Humans; Imidazoles; Immunosuppressive Agents; Piperidines; Pyrazoles; Rats; Rimonabant; Sirolimus; Status Epilepticus; Terminology as Topic | 2010 |
9 other study(ies) available for sr141716 and Aura
| Article | Year |
|---|---|
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Agonists; Cerebral Cortex; Electroencephalography; Endocannabinoids; Epilepsy; Epilepsy, Absence; Injections, Intraventricular; Male; Morpholines; Naphthalenes; Neural Pathways; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Seizures; Somatosensory Cortex; Thalamus | 2013 |
Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm.
Topics: Anilides; Animals; Bromodeoxyuridine; Calcium-Calmodulin-Dependent Protein Kinase Type 1; Cannabinoid Receptor Antagonists; Cinnamates; Disease Models, Animal; Epilepsy; gamma-Aminobutyric Acid; Gene Expression Regulation; Kindling, Neurologic; Male; Mice; Mice, Knockout; Neurogenesis; Neurons; Piperidines; Prosencephalon; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; TRPV Cation Channels | 2015 |
Soothing the seizures of children.
Topics: Adult; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Child, Preschool; Clinical Trials as Topic; Epilepsy; Humans; Models, Neurological; Piperidines; Pyrazoles; Rimonabant; Seizures, Febrile | 2008 |
Δ⁹-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats.
Topics: Animals; Cerebral Cortex; Competitive Bidding; Disease Models, Animal; Dronabinol; Drug Interactions; Epilepsy; Evoked Potentials; Female; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Pentylenetetrazole; Phosphorus Isotopes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant | 2010 |
CB1 receptor antagonism impairs the induction of epileptiform activity by group I metabotropic glutamate receptor activation.
Topics: Animals; Dose-Response Relationship, Drug; Epilepsy; Excitatory Postsynaptic Potentials; Methoxyhydroxyphenylglycol; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Metabotropic Glutamate; Rimonabant; Synaptic Transmission | 2010 |
The effect of the cannabinoid-receptor antagonist, SR141716, on the early stage of kainate-induced epileptogenesis in the adult rat.
Topics: Age Factors; Animals; Brain; Cannabinoid Receptor Antagonists; Convulsants; Disease Models, Animal; Electroencephalography; Epilepsy; Kainic Acid; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Recurrence; Rimonabant; Status Epilepticus | 2010 |
CB1 cannabinoid receptors and on-demand defense against excitotoxicity.
Topics: Animals; Arachidonic Acids; Brain; Brain-Derived Neurotrophic Factor; Cannabinoids; Endocannabinoids; Epilepsy; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Furans; gamma-Aminobutyric Acid; Gene Expression Regulation; Genes, Immediate-Early; Glutamic Acid; Glycerides; Hippocampus; In Vitro Techniques; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mitogen-Activated Protein Kinases; Mutation; Neurons; Neuroprotective Agents; Piperidines; Polyunsaturated Alkamides; Prosencephalon; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Signal Transduction | 2003 |
Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.
Topics: Action Potentials; Animals; Animals, Newborn; Benzoxazines; Cells, Cultured; Disease Models, Animal; Drug Interactions; Epilepsy; Hippocampus; Morpholines; Naphthalenes; Neurons; Patch-Clamp Techniques; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Synaptic Transmission | 2007 |
Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
Topics: Animals; Arachidonic Acids; Benzoxazines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electric Stimulation; Endocannabinoids; Epilepsy; Hippocampus; In Vitro Techniques; Male; Membrane Potentials; Morpholines; Naphthalenes; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Stereoisomerism; Synaptic Transmission | 1999 |